This is a promotional website intended for UK healthcare professionals (HCPs) only. Adverse event reporting can be found at the bottom of the page.
You have no items in your basket.
No products in the basket.
Protecting Against the Threat of Viral Diseases
Virexa® is a next-generation vaccine developed to help protect individuals from a range of serious viral infections. Built on Bavarian Nordic’s innovative vaccine technology, Virexa® delivers reliable immune response and long-lasting protection, supporting global efforts to reduce the impact of viral disease outbreaks.
There is no linked vaccine with the product, please select the appropriate vaccine in the product settings.
Find out more
14 August 2025
Virexa® is intended for the prevention of specific viral infections as indicated in the product’s approved prescribing information. Administration should be carried out by a qualified healthcare professional. Please consult the Summary of Product Characteristics (SmPC) and Patient Information Leaflet for detailed guidance on dosing, contraindications, and possible side effects.For medical advice, contact your healthcare provider.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard . Adverse events should also be reported to Bavarian Nordic: drug.safety@bavarian-nordic.com.
This site is intended for UK healthcare professionals only and contains information on Bavarian Nordic's medicines, educational materials, and more. Please click the appropriate button below to proceed.
By entering this site, you confirm that you are a UK healthcare professional. This site includes promotional content. Please be aware that some information may only be relevant to HCPs practicing in the UK.
Gain full access to all of our content by creating an account.